// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

The Impact of Elevated Doppler Resistive Indices in Renal Transplant Recipients with Delayed Graft Function.

D. Mikhail - American Transplant Congress (ATC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

The Impact of the New Kidney Allocation System on Living Donor Kidney Transplantation(LDTX) Among Patients in the Lowest Quintile of Expected Post-Transplant Survival (EPTS).

C. Rose - American Transplant Congress (ATC) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Molecular Phenotypes of Rejection in Kidney Transplant Biopsies.

P. Halloran - American Transplant Congress (ATC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Other

N/A

N/A

The Natural History of Kidney Rejection: How Do Molecular Disease States Change Over Time in Patients with Repeat Indication Biopsies?

J. Reeve - American Transplant Congress (ATC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Other

N/A

N/A

The TAKE-IT Intervention Improves Medication Adherence in Adolescent Kidney Transplant Recipients.

B. Foster - American Transplant Congress (ATC) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A novel mouse model of PI3 kinase pathway in metastatic Shh medulloblastoma

Michael Taylor - Society for Neuro-Oncology (SNO) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Doxycycline

Transcript Changes Associated with Graft Rejection Are Not Specific for Rejection Because They Are Shared with Tissue Responses to Wounding.

P. Halloran - American Transplant Congress (ATC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Other

N/A

N/A

Transplant Professionals' Attitudes and Approaches to the Living Kidney Donor-Recipient Relationship: Interview Study.

A. Ralph - American Transplant Congress (ATC) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

CD271 (p75NTR) as a novel diagnostic marker and therapeutic target for SHH medulloblastoma

Ludivine Coudiere-Morrison - Society for Neuro-Oncology (SNO) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Treating Hepatitis C+ Patients Before or After Kidney Transplantation: A Medical Decision Analysis.

B. Kiberd - American Transplant Congress (ATC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Convergence of BMI1 and CHD7 on ERK signalling in medulloblastoma

Xinyu Zhang - Society for Neuro-Oncology (SNO) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Use of Hepatitis C Infected Organs for Kidney Transplantation: A Cost-Effective Analysis.

B. Kiberd - American Transplant Congress (ATC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Use of Hepatitis C Infected Organs for Kidney Transplantation: A Medical Decision Analysis.

B. Kiberd - American Transplant Congress (ATC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Genes preserving stem cell state in Group 3 MB BTICs contribute to therapy evasion and relapse

Thusyanth Vijayakumar - Society for Neuro-Oncology (SNO) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Variability in Tacrolimus Concentrations Across Pediatric Solid Organ Transplants.

S. Min - American Transplant Congress (ATC) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tacrolimus

Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients.

N. Lam - American Transplant Congress (ATC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Gliomas in adolescents and young adults share several molecular features with their pediatric counterparts

Sunit Das - Society for Neuro-Oncology (SNO) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Willingness of Canadian ESRD Patients to Consider Transplant Tourism.

J. Gill - American Transplant Congress (ATC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Intellectual outcome in children with sensorineural hearing loss following treatment for embryonal brain tumors.

Iska Moxon-Emre - Society for Neuro-Oncology (SNO) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Investigating the role of the RNA binding protein, Musashi, in group 3 medulloblastoma

Chitra Venugopal - Society for Neuro-Oncology (SNO) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved